Skip to main navigation Skip to search Skip to main content

Safety and efficacy of recombinant human -Galactosidase, a replacement therapy in Fabry’s disease.

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalN Engl J Med
Volume345
StatePublished - 2001

Disciplines

  • Medicine and Health Sciences

Cite this